GlassScriptPhysician profile
Johny J Motran
NPI 1033315031
$3,082.42
in general payments reported to CMS, 2019-2025
25 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $439 · 2020: $118 · 2021: $223 · 2022: $1,585 · 2023: $300 · 2024: $266 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $717.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,200.00 | 2022 | |
| Organogenesis INC. | $380.31 | 2019-2025 | Puraply, Cygnus Dual, Simplimax |
| Nevro Corp. | $163.39 | 2023 | Senza |
| Convatec INC. | $148.36 | 2024 | |
| Horizon Therapeutics Plc | $142.02 | 2019-2021 | |
| Rikco International, LLC | $134.50 | 2019 | |
| Bioventus LLC | $124.99 | 2022 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Paratek Pharmaceuticals, INC. | $98.18 | 2020-2021 | |
| Smith+Nephew, INC. | $88.07 | 2020-2024 | Grafix |
| Musculoskeletal Transplant Foundation INC. | $87.72 | 2019 | |
| Linvatec Corporation | $83.72 | 2025 | Neospan, Allograft Tissue, Biobrace 23mm |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $66.59 | 2020-2022 | |
| Sebela Pharmaceuticals INC. | $51.78 | 2022-2023 | Naftin |
| Amgen INC. | $38.59 | 2025 | Krystexxa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $27.98 | 2022 | |
| Merck Sharp & Dohme LLC | $23.01 | 2019 | |
| Kerecis Limited | $20.91 | 2022 | |
| Melinta Therapeutics, LLC | $15.86 | 2019 | |
| Tactile Systems Technology INC | $14.48 | 2019 | |
| Averitas Pharma INC. | $13.52 | 2023 | Qutenza |
| Medtronic, INC. | $13.06 | 2021 | |
| Abbvie INC. | $12.13 | 2022 | |
| Hikma Pharmaceuticals USA | $11.05 | 2020 | |
| Ermi LLC | $10.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johny Motran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.